Valerie Sapozhnikova

Associate
Full contact info

Experience

RayzeBio Announces Upsized $357.6 Million IPO

September 19, 2023

Cooley advised RayzeBio, a targeted radiopharmaceutical company developing an innovative pipeline against solid tumor targets, on its upsized $357.6 million initial public offering.

Read more

Related contacts

Carlos Ramirez
Partner, San Diego
Charlie Kim
Partner, San Diego
Marya Postner
Partner, Palo Alto
Terren O'Connor
Associate, San Diego
Valerie Sapozhnikova
Associate, Los Angeles Downtown
Jayden Martinez
Associate, Colorado
Michelle Hunt
Associate
Todd Gluth
Partner, San Diego
Tony P. Guan
Associate, Los Angeles Santa Monica
Nathaniel Hearn Jr.
Associate, New York
Daniel Lac
Associate, San Diego
Natasha Leskovsek
Of Counsel, Washington DC
Phil Mitchell
Partner, New York
Alessandra Murata
Partner, Palo Alto
Kelly Nelle
Paralegal Specialist, San Diego
Rebecca Ross
Special Counsel, Washington DC
Jennifer Shanley
Special Counsel, New York
Jeffrey J. Tolin
Partner, New York
Francis Wheeler
Partner, Colorado

Related Practices & Industries

Turnstone Biologics Announces Upsized $80 Million IPO

July 26, 2023

Cooley advised Turnstone Biologics, a clinical-stage biotechnology company, on its upsized $80 million initial public offering.

Read more

Related contacts

Div Gupta
Partner, New York
Ryan Sansom
Partner, Boston
Lila Hope
Partner, Palo Alto
Alexa M. Smith (Ekman)
Associate, San Diego
Valerie Sapozhnikova
Associate, Los Angeles Downtown
Julianne Orr
Associate, San Francisco
Anitha Anne
Associate, San Francisco
Cathy Rude
Senior Paralegal, Boston
Natasha Leskovsek
Of Counsel, Washington DC
Phil Mitchell
Partner, New York
Alessandra Murata
Partner, Palo Alto
Tony P. Guan
Associate, Los Angeles Santa Monica
Elizabeth Anne Wright
Partner, Brussels
Jessica Koffel
Associate, Brussels
Aaron Pomeroy
Partner, Colorado
Rick Jantz
Associate, Los Angeles Santa Monica
Xander Lee
Partner, Los Angeles Santa Monica
Francis Wheeler
Partner, Colorado

Related Practices & Industries

ACELYRIN Announces Pricing of Upsized Initial Public Offering

May 15, 2023

Cooley advised Acelyrin, INC., a late-stage biopharmaceutical company, in its $621 million initial public offering, the second-largest biotechnology IPO and largest clinical-stage biotechnology IPO ever.

Read more

Related contacts

Chadwick Mills
Partner, San Francisco
Charlie Kim
Partner, San Diego
Anitha Anne
Associate, San Francisco
Barbara Mirza
Partner, Los Angeles Santa Monica
Xander Lee
Partner, Los Angeles Santa Monica
Joshua Mates
Partner, San Francisco
Phil Mitchell
Partner, New York
Brad Goldberg
Partner, New York
Peter Adams
Partner, San Diego
Lauren Creel
Partner, Palo Alto
Koji Fukumura
Partner, San Diego
Patrick Gibbs
Partner, Palo Alto
David Peinsipp
Partner, San Francisco
Barbara Borden
Partner, San Diego
David Navetta
Partner, Colorado
Patrick Van Eecke
Partner, Brussels
Shannon Eagan
Partner in Charge – Palo Alto, Palo Alto
Darren DeStefano
Partner, Reston
Francis Wheeler
Partner, Colorado
Thomas Welk
Senior Counsel, San Diego
Natasha Leskovsek
Of Counsel, Washington DC
Brett White
Of Counsel, Palo Alto
Dani Nazemian
Special Counsel, San Diego
Jennifer Shanley
Special Counsel, New York
Jacquelyn Burke
Special Counsel, Boston
Karen Tsai
Special Counsel, Washington DC
Miriam Petrillo
Special Counsel, Chicago
Andrew Nelms
Associate, San Francisco
David D. Kim
Associate, San Francisco
Lawrence Traylor
Associate, Los Angeles Santa Monica
Dionne A. Thomas
Associate, San Diego
Nathaniel Hearn Jr.
Associate, New York
Valerie Sapozhnikova
Associate, Los Angeles Downtown
Eileen Leman
Associate, Los Angeles Downtown
Kelly McCormick
Associate, San Francisco
Mor Agam
Associate, New York
Allison Kutner
Associate, New York
Madison (JJ) Meng
Associate, San Francisco
Rebecca Siegel
Associate, San Francisco
Rachel F. Katz
Associate, New York
Mari Dugas
Associate, Washington DC
Loriane Sangaré-Vayssac
Associate, Brussels
Megan Drill
Associate, San Diego
Amanda Pacheco
Associate, Palo Alto
Kristin R. Marshall
Associate, Washington DC
John T. Stellini
Associate, Palo Alto
Luke X. Blackett
Associate, San Francisco

Related Practices & Industries

LumiraDx Limited – $100.3 Million Follow-on Offering and Concurrent Private Placement

August 24, 2022

Cooley advised the underwriters in LumiraDx Limited’s $100.3 million aggregate financing, consisting of (1) a $75.3 million follow-on offering of 43,000,000 shares of common stock at a public offering price of $1.75 per share and (2) a $25.0 million concurrent private placement with the Bill & Melinda Gates Foundation. LumiraDx is a diagnostics company manufacturing and commercializing an innovative diagnostic platform that supports a broad menu of tests with lab-comparable performance at the point of care. Partners Denny Won, Kristin VanderPas, Charlie Kim and Dave Peinsipp led the Cooley team.

Related contacts

Denny Won
Partner, San Francisco
Kristin VanderPas
Partner, San Francisco
Charlie Kim
Partner, San Diego
David Peinsipp
Partner, San Francisco
Valerie Sapozhnikova
Associate, Los Angeles Downtown
Jesse Schulman
Associate, Washington DC
Mike Lam
Associate, Los Angeles Santa Monica

Related Practices & Industries

Pliant Therapeutics – $230.0 Million Follow-on Offering

August 24, 2022

Cooley advised the underwriters in Pliant Therapeutics’ $230.0 million follow-on offering of 12,432,432 shares of common stock at a public offering price of $18.50 per share. Pliant is a clinical-stage biotechnology company discovering and developing novel therapies for the treatment of fibrosis. Partners Denny Won, Charlie Kim, Kristin VanderPas and Dave Peinsipp led the Cooley team.

Related contacts

Denny Won
Partner, San Francisco
Charlie Kim
Partner, San Diego
Kristin VanderPas
Partner, San Francisco
David Peinsipp
Partner, San Francisco
Valerie Sapozhnikova
Associate, Los Angeles Downtown
Madison (JJ) Meng
Associate, San Francisco
Marjorie Roesser
Associate, San Francisco

Related Practices & Industries

View more